LOBOCYCLAMIDE-A
Compound with spectra: 1 NMR
| SpectraBase Compound ID | HDPE851p5Dg |
|---|---|
| InChI | InChI=1S/C59H95N11O15/c1-11-15-16-17-37-27-47(75)62-45(31-72)55(81)63-40(14-4)59(85)70-30-39(74)28-46(70)56(82)64-41(22-23-71)52(78)66-44(26-36-18-20-38(73)21-19-36)53(79)65-43(25-33(7)8)54(80)68-50(35(10)13-3)58(84)69-49(34(9)12-2)57(83)67-42(24-32(5)6)51(77)60-29-48(76)61-37/h14,18-21,32-35,37,39,41-46,49-50,71-74H,11-13,15-17,22-31H2,1-10H3,(H,60,77)(H,61,76)(H,62,75)(H,63,81)(H,64,82)(H,65,79)(H,66,78)(H,67,83)(H,68,80)(H,69,84)/b40-14-/t34?,35?,37-,39-,41+,42+,43-,44+,45-,46+,49+,50+/m0/s1 |
| InChIKey | UCGPFEODLDUNCV-DHUAEXHOSA-N |
| Mol Weight | 1198.5 g/mol |
| Molecular Formula | C59H95N11O15 |
| Exact Mass | 1197.700911 g/mol |
| Enantiomer InChIKey | UCGPFEODLDUNCV-DBMGWUQHSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
LOLOATIN-C;CYClIC-(L-ASPARAGINYL-L-ASPARTYL-L-TRYPTOPHANE-L-VALYL-L-ORNITHINYL-L-LEUCYL-D-TYROSYL-L-PROLYL-L-TRYPTOPHANE-D-PHENYLALANYL)
PHORIOSPONGIN-A
LOLOATIN-B;CYClIC-(L-ASPARAGINYL-L-ASPARTYL-L-TRYPTOPHANE-L-VALYL-L-ORNITHINYL-L-LEUCYL-D-TYROSYL-L-PROLYL-L-PHENYLALANYL-D-PHENYLALANYL)
PHORIOSPONGIN-B
CYCLOLINOPEPTIDE-H;CYCLO-(PRO-PHE-PHE-TRP-ILE-MSO-LEU-MET)
STREPTOCIDIN-D
GYPSOPHIN-B;CYCLO-[PROLINE(1)-PHENYLALANINE(2)-PROLINE(3)-PROLINE(4)-SERINE(5)-THREONINE(6)-GLYCINE(7)-LEUCINE(8)-PROLINE(9)-ISOLEUCINE(10)]
CYCLOLOTHISTIDE_A
TRICHORZIANINE-1938;TA-1938
KAWAGUCHIPEPTIN_B
| Title | Journal or Book | Year |
|---|---|---|
| Lobocyclamides A−C, Lipopeptides from a Cryptic Cyanobacterial Mat Containing Lyngbya confervoides | The Journal of Organic Chemistry | 2002 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.